Report cover image

Global Cat Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 192 Pages
SKU # APRC20552856

Description

Summary

According to APO Research, The global Cat Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cat Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cat Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Cat Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Cat Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Cat Vaccines include Zoetis (Pfizer), Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Merck Animal Health, Heska Co. and Ceva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cat Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Cat Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Cat Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cat Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Cat Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Cat Vaccines sales, projected growth trends, production technology, application and end-user industry.

Cat Vaccines Segment by Company

Zoetis (Pfizer)
Eli Lilly
Bayer Healthcare
Virbac
Vetoquinol S.A
Merial (Sanofi)
Merck Animal Health
Heska Co.
Ceva
Boehringer Ingelheim
Cat Vaccines Segment by Type

DNA Vaccines
Conjugate Vaccines
Attenuated Live Vaccines
Toxoid Vaccines
Inactivated Vaccines
Subunit Vaccines
Recombinant Vaccines
Cat Vaccines Segment by Application

Below 6 Months
Above 6 Months
Cat Vaccines Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cat Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cat Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cat Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cat Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cat Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cat Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cat Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Cat Vaccines Market Size, 2020 VS 2024 VS 2031
1.3 Global Cat Vaccines Market Size Estimates and Forecasts (2020-2031)
1.4 Global Cat Vaccines Sales Estimates and Forecasts (2020-2031)
1.5 Global Cat Vaccines Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Cat Vaccines Market Dynamics
2.1 Cat Vaccines Industry Trends
2.2 Cat Vaccines Industry Drivers
2.3 Cat Vaccines Industry Opportunities and Challenges
2.4 Cat Vaccines Industry Restraints
3 Cat Vaccines Market by Manufacturers
3.1 Global Cat Vaccines Revenue by Manufacturers (2020-2025)
3.2 Global Cat Vaccines Sales by Manufacturers (2020-2025)
3.3 Global Cat Vaccines Average Sales Price by Manufacturers (2020-2025)
3.4 Global Cat Vaccines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Cat Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Cat Vaccines Manufacturers, Product Type & Application
3.7 Global Cat Vaccines Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Cat Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Cat Vaccines Players Market Share by Revenue in 2024
3.8.3 2024 Cat Vaccines Tier 1, Tier 2, and Tier 3
4 Cat Vaccines Market by Type
4.1 Cat Vaccines Type Introduction
4.1.1 DNA Vaccines
4.1.2 Conjugate Vaccines
4.1.3 Attenuated Live Vaccines
4.1.4 Toxoid Vaccines
4.1.5 Inactivated Vaccines
4.1.6 Subunit Vaccines
4.1.7 Recombinant Vaccines
4.2 Global Cat Vaccines Sales by Type
4.2.1 Global Cat Vaccines Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Cat Vaccines Sales by Type (2020-2031)
4.2.3 Global Cat Vaccines Sales Market Share by Type (2020-2031)
4.3 Global Cat Vaccines Revenue by Type
4.3.1 Global Cat Vaccines Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Cat Vaccines Revenue by Type (2020-2031)
4.3.3 Global Cat Vaccines Revenue Market Share by Type (2020-2031)
5 Cat Vaccines Market by Application
5.1 Cat Vaccines Application Introduction
5.1.1 Below 6 Months
5.1.2 Above 6 Months
5.2 Global Cat Vaccines Sales by Application
5.2.1 Global Cat Vaccines Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Cat Vaccines Sales by Application (2020-2031)
5.2.3 Global Cat Vaccines Sales Market Share by Application (2020-2031)
5.3 Global Cat Vaccines Revenue by Application
5.3.1 Global Cat Vaccines Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Cat Vaccines Revenue by Application (2020-2031)
5.3.3 Global Cat Vaccines Revenue Market Share by Application (2020-2031)
6 Global Cat Vaccines Sales by Region
6.1 Global Cat Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Cat Vaccines Sales by Region (2020-2031)
6.2.1 Global Cat Vaccines Sales by Region (2020-2025)
6.2.2 Global Cat Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Cat Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Cat Vaccines Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Cat Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Cat Vaccines Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Cat Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Cat Vaccines Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Cat Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Cat Vaccines Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Cat Vaccines Revenue by Region
7.1 Global Cat Vaccines Revenue by Region
7.1.1 Global Cat Vaccines Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Cat Vaccines Revenue by Region (2020-2025)
7.1.3 Global Cat Vaccines Revenue by Region (2026-2031)
7.1.4 Global Cat Vaccines Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Cat Vaccines Revenue (2020-2031)
7.2.2 North America Cat Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Cat Vaccines Revenue (2020-2031)
7.3.2 Europe Cat Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Cat Vaccines Revenue (2020-2031)
7.4.2 Asia-Pacific Cat Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Cat Vaccines Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Cat Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Zoetis (Pfizer)
8.1.1 Zoetis (Pfizer) Comapny Information
8.1.2 Zoetis (Pfizer) Business Overview
8.1.3 Zoetis (Pfizer) Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Zoetis (Pfizer) Cat Vaccines Product Portfolio
8.1.5 Zoetis (Pfizer) Recent Developments
8.2 Eli Lilly
8.2.1 Eli Lilly Comapny Information
8.2.2 Eli Lilly Business Overview
8.2.3 Eli Lilly Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Eli Lilly Cat Vaccines Product Portfolio
8.2.5 Eli Lilly Recent Developments
8.3 Bayer Healthcare
8.3.1 Bayer Healthcare Comapny Information
8.3.2 Bayer Healthcare Business Overview
8.3.3 Bayer Healthcare Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Bayer Healthcare Cat Vaccines Product Portfolio
8.3.5 Bayer Healthcare Recent Developments
8.4 Virbac
8.4.1 Virbac Comapny Information
8.4.2 Virbac Business Overview
8.4.3 Virbac Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Virbac Cat Vaccines Product Portfolio
8.4.5 Virbac Recent Developments
8.5 Vetoquinol S.A
8.5.1 Vetoquinol S.A Comapny Information
8.5.2 Vetoquinol S.A Business Overview
8.5.3 Vetoquinol S.A Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Vetoquinol S.A Cat Vaccines Product Portfolio
8.5.5 Vetoquinol S.A Recent Developments
8.6 Merial (Sanofi)
8.6.1 Merial (Sanofi) Comapny Information
8.6.2 Merial (Sanofi) Business Overview
8.6.3 Merial (Sanofi) Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Merial (Sanofi) Cat Vaccines Product Portfolio
8.6.5 Merial (Sanofi) Recent Developments
8.7 Merck Animal Health
8.7.1 Merck Animal Health Comapny Information
8.7.2 Merck Animal Health Business Overview
8.7.3 Merck Animal Health Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Merck Animal Health Cat Vaccines Product Portfolio
8.7.5 Merck Animal Health Recent Developments
8.8 Heska Co.
8.8.1 Heska Co. Comapny Information
8.8.2 Heska Co. Business Overview
8.8.3 Heska Co. Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Heska Co. Cat Vaccines Product Portfolio
8.8.5 Heska Co. Recent Developments
8.9 Ceva
8.9.1 Ceva Comapny Information
8.9.2 Ceva Business Overview
8.9.3 Ceva Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Ceva Cat Vaccines Product Portfolio
8.9.5 Ceva Recent Developments
8.10 Boehringer Ingelheim
8.10.1 Boehringer Ingelheim Comapny Information
8.10.2 Boehringer Ingelheim Business Overview
8.10.3 Boehringer Ingelheim Cat Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Boehringer Ingelheim Cat Vaccines Product Portfolio
8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Cat Vaccines Value Chain Analysis
9.1.1 Cat Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Cat Vaccines Production Mode & Process
9.2 Cat Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Cat Vaccines Distributors
9.2.3 Cat Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.